Mechanisms Involved in Chemoresistance in Ovarian Cancer
Chemotherapy is a major treatment modality for ovarian cancer, but chemoresistance is a clinical problem that compromises the efficiency of treatment and finally results in treatment failure. The development of resistance to chemotherapeutic agents might be related to multiple mechanisms such as alt...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-09-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455909601431 |
id |
doaj-85f14c6a8da2468bb4141e5c7405bbb1 |
---|---|
record_format |
Article |
spelling |
doaj-85f14c6a8da2468bb4141e5c7405bbb12020-11-24T21:18:18ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592005-09-0144320921710.1016/S1028-4559(09)60143-1Mechanisms Involved in Chemoresistance in Ovarian CancerKar-San LingGin-Den ChenHorng-Jyh TsaiMaw-Sheng LeePo-Hui WangChemotherapy is a major treatment modality for ovarian cancer, but chemoresistance is a clinical problem that compromises the efficiency of treatment and finally results in treatment failure. The development of resistance to chemotherapeutic agents might be related to multiple mechanisms such as alterations in drug transport, changes in cellular proteins involved in detoxification, altered drug target, changes in DNA repair mechanisms, and increased tolerance to drug-induced DNA damage. This article is a summary of the various mechanisms that are involved in chemoresistance in ovarian cancer.http://www.sciencedirect.com/science/article/pii/S1028455909601431chemoresistancechemotherapyovarian cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kar-San Ling Gin-Den Chen Horng-Jyh Tsai Maw-Sheng Lee Po-Hui Wang |
spellingShingle |
Kar-San Ling Gin-Den Chen Horng-Jyh Tsai Maw-Sheng Lee Po-Hui Wang Mechanisms Involved in Chemoresistance in Ovarian Cancer Taiwanese Journal of Obstetrics & Gynecology chemoresistance chemotherapy ovarian cancer |
author_facet |
Kar-San Ling Gin-Den Chen Horng-Jyh Tsai Maw-Sheng Lee Po-Hui Wang |
author_sort |
Kar-San Ling |
title |
Mechanisms Involved in Chemoresistance in Ovarian Cancer |
title_short |
Mechanisms Involved in Chemoresistance in Ovarian Cancer |
title_full |
Mechanisms Involved in Chemoresistance in Ovarian Cancer |
title_fullStr |
Mechanisms Involved in Chemoresistance in Ovarian Cancer |
title_full_unstemmed |
Mechanisms Involved in Chemoresistance in Ovarian Cancer |
title_sort |
mechanisms involved in chemoresistance in ovarian cancer |
publisher |
Elsevier |
series |
Taiwanese Journal of Obstetrics & Gynecology |
issn |
1028-4559 |
publishDate |
2005-09-01 |
description |
Chemotherapy is a major treatment modality for ovarian cancer, but chemoresistance is a clinical problem that compromises the efficiency of treatment and finally results in treatment failure. The development of resistance to chemotherapeutic agents might be related to multiple mechanisms such as alterations in drug transport, changes in cellular proteins involved in detoxification, altered drug target, changes in DNA repair mechanisms, and increased tolerance to drug-induced DNA damage. This article is a summary of the various mechanisms that are involved in chemoresistance in ovarian cancer. |
topic |
chemoresistance chemotherapy ovarian cancer |
url |
http://www.sciencedirect.com/science/article/pii/S1028455909601431 |
work_keys_str_mv |
AT karsanling mechanismsinvolvedinchemoresistanceinovariancancer AT gindenchen mechanismsinvolvedinchemoresistanceinovariancancer AT horngjyhtsai mechanismsinvolvedinchemoresistanceinovariancancer AT mawshenglee mechanismsinvolvedinchemoresistanceinovariancancer AT pohuiwang mechanismsinvolvedinchemoresistanceinovariancancer |
_version_ |
1726009806028800000 |